论文部分内容阅读
美国克利夫兰消息:心房钠尿因子(ANF)的初步临床应用表明,这种内源性调节物对人体内盐和水潴留的功效和在动物体内的功效一样。但研究人员尚不能确定ANF在治疗高血压、先天性心力衰竭和其它疾病中的作用。以Robert J Cody为首的纽约医院和康奈尔大学的研究组做了两项研究,探讨ANF在个体中对水和盐负荷的作用。在第一项研究中,三个小组中每组有5至6名正常血压的自愿受试者,以0.01、0.03或0.1微克/公斤体重
Cleveland, United States: A preliminary clinical application of atrial natriuretic factor (ANF) indicates that this endogenous regulator has the same effect on salt and water retention in humans as it does on animals. But researchers are not yet certain about the role of ANF in the treatment of hypertension, congenital heart failure and other diseases. Two studies were conducted by New York Hospital led by Robert J Cody and Cornell’s research team to investigate the effects of ANF on water and salt loading in individuals. In the first study, five to six volunteers with normotensive blood pressure in each of the three subgroups received either 0.01, 0.03 or 0.1 μg / kg body weight